Schwartz–Jampel syndrome: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[File:Autosomal_recessive_-_en.svg| | {{SI}} | ||
{{Infobox medical condition | |||
| name = Schwartz–Jampel syndrome | |||
| image = [[File:Autosomal_recessive_-_en.svg|200px]] | |||
| caption = Schwartz–Jampel syndrome is inherited in an [[autosomal recessive]] pattern. | |||
| synonyms = Chondrodystrophic myotonia | |||
| pronounce = | |||
| specialty = [[Medical genetics]] | |||
| symptoms = [[Myotonia]], [[dwarfism]], [[joint contractures]], [[muscle hypertrophy]] | |||
| onset = [[Infancy]] or [[early childhood]] | |||
| duration = Lifelong | |||
| causes = Mutations in the [[HSPG2]] gene | |||
| risks = | |||
| diagnosis = [[Genetic testing]], [[clinical evaluation]] | |||
| differential = [[Myotonic dystrophy]], [[Stiff person syndrome]] | |||
| treatment = [[Physical therapy]], [[medications]] to manage symptoms | |||
| medication = [[Muscle relaxants]], [[anticonvulsants]] | |||
| frequency = Rare | |||
| deaths = | |||
}} | |||
'''Schwartz–Jampel syndrome''' (SJS), also known as '''chondrodystrophic myotonia''', is a rare [[genetic disorder]] characterized by [[myotonia]], [[skeletal abnormalities]], and [[growth retardation]]. It was first described by Dr. Oscar Schwartz and Dr. Robert Jampel in 1962. | |||
==Signs and Symptoms== | ==Signs and Symptoms== | ||
Individuals with Schwartz–Jampel syndrome typically present with: | Individuals with Schwartz–Jampel syndrome typically present with: | ||
| Line 7: | Line 26: | ||
* [[Facial features]]: A characteristic facial appearance with blepharophimosis, a small mouth, and a pursed-lip appearance. | * [[Facial features]]: A characteristic facial appearance with blepharophimosis, a small mouth, and a pursed-lip appearance. | ||
* [[Growth retardation]]: Delayed growth and development. | * [[Growth retardation]]: Delayed growth and development. | ||
==Genetics== | ==Genetics== | ||
Schwartz–Jampel syndrome is inherited in an [[autosomal recessive]] manner. Mutations in the [[HSPG2]] gene, which encodes the protein [[perlecan]], are responsible for the condition. Perlecan is essential for the structural integrity of the extracellular matrix in various tissues. | Schwartz–Jampel syndrome is inherited in an [[autosomal recessive]] manner. Mutations in the [[HSPG2]] gene, which encodes the protein [[perlecan]], are responsible for the condition. Perlecan is essential for the structural integrity of the extracellular matrix in various tissues. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Schwartz–Jampel syndrome is based on clinical evaluation, family history, and genetic testing. [[Electromyography]] (EMG) can be used to detect myotonia, and [[radiographic imaging]] can reveal skeletal abnormalities. | Diagnosis of Schwartz–Jampel syndrome is based on clinical evaluation, family history, and genetic testing. [[Electromyography]] (EMG) can be used to detect myotonia, and [[radiographic imaging]] can reveal skeletal abnormalities. | ||
==Treatment== | ==Treatment== | ||
There is no cure for Schwartz–Jampel syndrome, but treatment focuses on managing symptoms. This may include: | There is no cure for Schwartz–Jampel syndrome, but treatment focuses on managing symptoms. This may include: | ||
| Line 19: | Line 35: | ||
* [[Medications]]: Such as [[muscle relaxants]] to alleviate myotonia. | * [[Medications]]: Such as [[muscle relaxants]] to alleviate myotonia. | ||
* [[Orthopedic surgery]]: To correct severe skeletal deformities. | * [[Orthopedic surgery]]: To correct severe skeletal deformities. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for individuals with Schwartz–Jampel syndrome varies. While the condition is chronic, many individuals can lead relatively normal lives with appropriate management of symptoms. | The prognosis for individuals with Schwartz–Jampel syndrome varies. While the condition is chronic, many individuals can lead relatively normal lives with appropriate management of symptoms. | ||
==See also== | |||
== | |||
* [[Myotonia]] | * [[Myotonia]] | ||
* [[Genetic disorder]] | * [[Genetic disorder]] | ||
| Line 31: | Line 45: | ||
* [[Physical therapy]] | * [[Physical therapy]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Musculoskeletal disorders]] | [[Category:Musculoskeletal disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{Genetic-disorder-stub}} | {{Genetic-disorder-stub}} | ||
Latest revision as of 15:55, 8 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Schwartz–Jampel syndrome | |
|---|---|
| |
| Synonyms | Chondrodystrophic myotonia |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Myotonia, dwarfism, joint contractures, muscle hypertrophy |
| Complications | N/A |
| Onset | Infancy or early childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the HSPG2 gene |
| Risks | |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Myotonic dystrophy, Stiff person syndrome |
| Prevention | N/A |
| Treatment | Physical therapy, medications to manage symptoms |
| Medication | Muscle relaxants, anticonvulsants |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | |
Schwartz–Jampel syndrome (SJS), also known as chondrodystrophic myotonia, is a rare genetic disorder characterized by myotonia, skeletal abnormalities, and growth retardation. It was first described by Dr. Oscar Schwartz and Dr. Robert Jampel in 1962.
Signs and Symptoms[edit]
Individuals with Schwartz–Jampel syndrome typically present with:
- Myotonia: Prolonged muscle contractions leading to stiffness.
- Skeletal abnormalities: Including short stature, joint contractures, and kyphoscoliosis.
- Facial features: A characteristic facial appearance with blepharophimosis, a small mouth, and a pursed-lip appearance.
- Growth retardation: Delayed growth and development.
Genetics[edit]
Schwartz–Jampel syndrome is inherited in an autosomal recessive manner. Mutations in the HSPG2 gene, which encodes the protein perlecan, are responsible for the condition. Perlecan is essential for the structural integrity of the extracellular matrix in various tissues.
Diagnosis[edit]
Diagnosis of Schwartz–Jampel syndrome is based on clinical evaluation, family history, and genetic testing. Electromyography (EMG) can be used to detect myotonia, and radiographic imaging can reveal skeletal abnormalities.
Treatment[edit]
There is no cure for Schwartz–Jampel syndrome, but treatment focuses on managing symptoms. This may include:
- Physical therapy: To improve mobility and reduce joint contractures.
- Medications: Such as muscle relaxants to alleviate myotonia.
- Orthopedic surgery: To correct severe skeletal deformities.
Prognosis[edit]
The prognosis for individuals with Schwartz–Jampel syndrome varies. While the condition is chronic, many individuals can lead relatively normal lives with appropriate management of symptoms.
See also[edit]
This article is a genetic disorder stub. You can help WikiMD by expanding it!
